![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NetScientific Receives CE Mark for Immunoassay
NetScientific Receives CE Mark for Immunoassay
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Netscientific_Logo.gif?t=1533337468&width=430)
August 3, 2018
NetScientific gained the CE Mark for its ProteaseTag active Pproteinase-3 immunoassay and announced its firm commercial sale to a US biotech company.
The company’s Plasmin and Neutrophil Elastase immunoassays have also received the CE Mark, and development is underway for further immunoassays.
The Pproteinase-3 immunoassay is designed for clinical researchers investigating chronic respiratory conditions, such as cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease, in both commercial and academic areas.
Upcoming Events
-
21Oct